PyInvesting

Market research

002868.SHE Lifecome Biochemistry Co., Ltd

SHE CNY Healthcare

Latest close

18.05 —

As of 30 Oct 2026

Test a moving-average rule with historical data.

Market facts
Market cap
3B
P/E ratio
Not available
Analyst target
Not available
Dividend yield
Not available
Beta
0.79

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 7 months ago

Lifecome Biochemistry Co., Ltd is currently in a long term downtrend where the price is trading 10.5% below its 200 day moving average.

From a valuation standpoint, the stock is 36.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 6.1.

Lifecome Biochemistry Co., Ltd's total revenue sank by 19.3% to $67M since the same quarter in the previous year.

Its net income has dropped by 100.1% to $-29K since the same quarter in the previous year.

Finally, its free cash flow fell by 99.2% to $-78M since the same quarter in the previous year.

Based on the above factors, Lifecome Biochemistry Co., Ltd gets an overall score of 1/5.